ChIP assay with E2f1 and E2f3 upon acute Rb family deletion in primary cTKO liver (d0, d4) and in TKO HCC showed an inverse evolution of E2f1- and E2f3-binding intensity during TKO HCC progression (Fig. 7a,b). This evidence concerns the gene E2F3 and hepatocellular carcinoma.